Description
What it is
A synthetic ACTH analog developed in Russia and approved there for stroke recovery research. Backed by decades of Russian and Eastern European published studies.
Why it’s studied
Semax has been shown to significantly elevate BDNF (brain-derived neurotrophic factor) — one of the most-studied markers in neuroplasticity, cognition, and neural repair research.
Key research findings
-
Significant BDNF elevation in cognitive and stroke recovery research (Russian published studies)
-
Documented neuroprotective effects in animal models of cerebral ischemia
-
Approved in Russia for clinical use in stroke and cognitive impairment research